S13: #116: Empowering Women's Health through Access to Contraception in Low/Middle Income Countries

Women and girls in low/middle-income countries are facing an urgent unmet need for modern contraception. This World Contraception Day, join guest host Sophie Park, Managing Director at G4A Digital Health Bayer in conversation with Dr. Ariane de Hoog, Lead Access to Medicine, Community Engagement at Bayer, and Titilola Olaolu-Hassan, Co-Founder & COO at Zuri Health, for this vital discussion on harnessing digital health solutions to empower women and enhance healthcare accessibility in Africa. Topics include: [00:02:14] Background to Bayer’s interest in empowering Women’s health. [00:05:05] Zuri Health: Affordable healthcare for underserved communities. [00:06:28] Impact goals behind Zuri becoming a G4A Portfolio company. [00:11:37] How the Zuri Health platform directly improves girls' and women's access to healthcare. [00:14:08] The future beyond family planning for Zuri Health in partnership with Bayer. [00:15:53] Bayer’s impact goal to provide 100 million women access to modern contraception by 2030. [00:20:23] Empowering women to make informed decisions irrespective of location Guest & Host Links Connect with Dan Kendall on LinkedIn Connect with Sophie Park on LinkedIn Connect with Dr. Ariane de Hoog on LinkedIn Connect with Titilola Olaolu-Hassan on LinkedIn Bayer G4A Zuri Health - Your-Life website - complimentary access to an array of educational and training resources on adolescent health and contraceptive counselling Digital Health Today would not be possible without the support of leading organizations. Thank you to: Presenting Partner: Amalgam Rx Contributing Partners and Sponsors: LSI | Lindus Health | Bayer G4A Connect on Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Connect on Health Podcast Network: Browse Shows | Linkedin | Twitter | Facebook | Instagram Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.